The tweet was deleted by the author.
But we saved everything 🙂.
West Pharmaceutical is inviting attendees to meet their experts at InnoPack Mumbai today at Booth B2.
West Pharmaceutical experts Vikrant Chadawar and Bill Matakas will be present at the event. Details are being clarified.
WST is currently trading at $323.59, which is just above the MA-20 ($320.86) but remains well above the MA-50 ($303.72) and MA-200 ($271.23), confirming a strong medium- and long-term uptrend with some short-term consolidation. The Ichimoku Kijun at $316.36 sits below the current price and acts as immediate support; near-term support is defined by the Kijun and MA-20, while MA-50 and MA-200 offer deeper key support. On the resistance side, MA-5 and MA-10 are closely overhead, with the nearest key resistance at the recent weekly top near $329.27.
Momentum on D1 remains mixed, as MACD signals a strong buy while ADX suggests moderate trend strength. RSI is comfortably in bullish territory at 56.12, but Stoch RSI indicates oversold conditions, and CCI remains neutral. BBP on D1 reveals recent overbought pressure, though intraday lower timeframes suggest sellers have gained control. Awesome Oscillator does not confirm the directional move. WST has fallen $5.23 (1.59%) from the prior weekly close of $328.82, with the price now at the very bottom of its weekly range; weekly volatility stands at 3.51%. The tone has shifted to a clear retreat from the week’s high. In today’s session, WST has posted a notable decline of 1.82%, highlighting renewed bearish sentiment.
Looking ahead, the expected trading range for the next week is $315 to $328, which remains comfortably above the 52-week low of $206.80 and not far below the all-time high of $336.82. With three out of four key weekly indicators (RSI-W1, ADX-W1, MACD-W1, MA-50-W1) signaling "Buy," the probability of a further price increase is high (more than 80%), making declines much less likely. The baseline scenario points to a sideways corridor between $315 and $328. A bullish scenario could see WST break above $329 and attempt to retest its 52-week high, while a bearish scenario would require a sustained drop below $316, exposing further downside toward stronger medium-term supports.
Previously it was reported that West Pharmaceutical exhibited a strong bullish technical profile, with positive momentum and expectations of continued upside. The current analysis builds on this outlook, emphasizing that traders should monitor for sustained momentum or signs of a shift, particularly around pivotal support and resistance levels that could define the next directional move.